Talks
PVO in Frontline CLL
March 18, 2026
Pirtobrutinib Versus Ibrutinib
March 11, 2026
BRUIN CLL-313: Phase III Trial
March 4, 2026
AV in CLL
February 25, 2026
Frontline BTK Inhibitor Therapy
February 20, 2026
Close button
Why are you reporting this TALK?